Trial Profile
Two Weeks of Low Molecular Weight Heparin for Distal Vein Thrombosis (TWISTER).
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Enoxaparin sodium (Primary)
- Indications Deep vein thrombosis; Pulmonary embolism; Venous thromboembolism
- Focus Therapeutic Use
- Acronyms TWISTER
- 10 Dec 2010 New trial record
- 03 Dec 2010 Additional lead investigator (Epidem M) identified as reported by ClinicalTrials.gov.